Banmeet Anand
Corporate Officer/Principal at HARPOON THERAPEUTICS, INC.
Profile
Banmeet Anand is currently the Senior Vice President-Translational Medicine at Harpoon Therapeutics, Inc. Prior to this, he worked as the Vice President & Head-Nonclinical Development at Molecular Templates, Inc. He holds a doctorate degree from the University of Missouri.
Banmeet Anand active positions
Companies | Position | Start |
---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-07-05 |
Former positions of Banmeet Anand
Companies | Position | End |
---|---|---|
MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - |
Training of Banmeet Anand
University of Missouri | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Private companies | 1 |
---|---|
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Banmeet Anand